Enforcement or recall ·
FDA warned 18 websites selling unapproved botulinum toxin
U.S. Food & Drug Administration · FDA news release, 2025-11-05
FDA issued 18 warning letters to owners of websites illegally marketing unapproved and misbranded botulinum toxin products, and restated that FDA-approved botulinum toxin products are available only with a prescription and should come from an authorized source.
- What this source establishes
- That FDA acted against specific websites selling unapproved or misbranded botulinum toxin, and that approved products are prescription-only.
- What it does not establish
- Whether a particular clinic's vial is genuine or where it was bought. The carton, the vial and the practice's supplier are what speak to that.
The official record (opens in a new tab) · checked Sep 25, 2026